☰

Lan G. Coffman, Ph.D. - Publications

Affiliations: 
2008 Wake Forest University School of Medicine, Winston-Salem, NC, United States 
Area:
Cell Biology, Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Atiya HI, Gorecki G, Garcia GL, Frisbie LG, Baruwal R, Coffman L. Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells. Biomolecules. 13. PMID 38002286 DOI: 10.3390/biom13111604  0.335
2022 Atiya HI, Frisbie L, Goldfeld E, Orellana T, Donellan N, Modugno F, Calderon M, Watkins SC, Zhang R, Elishaev E, Soong TR, Vlad AM, Coffman LG. Endometriosis-associated mesenchymal stem cells support ovarian clear cell carcinoma through iron regulation. Cancer Research. PMID 36219681 DOI: 10.1158/0008-5472.CAN-22-1294  0.428
2022 Frisbie L, Buckanovich RJ, Coffman L. Carcinoma Associated Mesenchymal Stem/Stromal Cells - Architects of the Pro-tumorigenic tumor microenvironment. Stem Cells (Dayton, Ohio). PMID 35583414 DOI: 10.1093/stmcls/sxac036  0.337
2021 Atiya HI, Orellana TJ, Wield A, Frisbie L, Coffman LG. An Orthotopic Mouse Model of Ovarian Cancer using Human Stroma to Promote Metastasis. Journal of Visualized Experiments : Jove. PMID 33843939 DOI: 10.3791/62382  0.353
2020 Fan H, Atiya HI, Wang Y, Pisanic TR, Wang TH, Shih IM, Foy KK, Frisbie L, Buckanovich RJ, Chomiak AA, Tiedemann RL, Rothbart SB, Chandler C, Shen H, Coffman LG. Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis. Cell Reports. 33: 108473. PMID 33296650 DOI: 10.1016/j.celrep.2020.108473  0.355
2020 Brown JR, Chan DK, Shank JJ, Griffith KA, Fan H, Szulawski R, Yang K, Reynolds RK, Johnston C, McLean K, Uppal S, Liu JR, Cabrera L, Taylor SE, Orr BC, ... ... Coffman L, et al. Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer. Jci Insight. PMID 32369446 DOI: 10.1172/Jci.Insight.133247  0.387
2020 Atiya H, Frisbie L, Pressimone C, Coffman L. Mesenchymal Stem Cells in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1234: 31-42. PMID 32040853 DOI: 10.1007/978-3-030-37184-5_3  0.449
2020 Goldfeld E, Atiya H, Frisbie L, Coffman LG. Defining the tumor cell: CA-MSC interactions which mediate ovarian cancer metastasis. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E18072  0.401
2020 Taylor SE, Wield A, Fang Y, Bhargava R, Lang S, Tseng G, Coffman LG, Oesterreich S. Endocrine biomarkers in low-grade serous ovarian cancers (LGSC) and serous ovarian tumors of low malignant potential (LMP). Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E18045  0.39
2020 Pressimone C, Atiya HI, Frisbie L, Coffman L. Abstract 1446: Mitochondrial transfer in the ovarian tumor microenvironment contributes to tumor stem cell phenotypes Immunology. DOI: 10.1158/1538-7445.Am2020-1446  0.34
2019 Bai S, Zhu W, Coffman L, Vlad A, Schwartz LE, Elishaev E, Drapkin R, Buckanovich RJ. CD105 Is Expressed in Ovarian Cancer Precursor Lesions and Is Required for Metastasis to the Ovary. Cancers. 11. PMID 31684072 DOI: 10.3390/Cancers11111710  0.363
2019 Chandler C, Liu T, Buckanovich R, Coffman LG. The double edge sword of fibrosis in cancer. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 30871956 DOI: 10.1016/J.Trsl.2019.02.006  0.431
2019 Frisbie LG, Shen H, Coffman L. Abstract TMIM-066: EZH2 REGULATES THE EPIGENETIC REPROGRAMMING OF OVARIAN CANCER PROMOTING CARCINOMA-ASSOCIATED MESENCHYMAL STEM CELLS Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-066  0.413
2019 Cillo AR, Chuckran CA, Liao M, Modugno F, Edwards R, Coffman L, Vignali DAA, Bruno TC. Abstract TMIM-063: TARGETING NEUROPILIN-1+ T REGULATORY CELLS IN PATIENTS WITH HIGH GRADE SEROUS OVARIAN CANCER DECREASES TREG-SPECIFIC SUPPRESSION OF CD8+ T CELLS Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-063  0.392
2018 Coffman LG, Pearson AT, Frisbie LG, Freeman Z, Christie E, Bowtell DD, Buckanovich RJ. Ovarian carcinoma-associated mesenchymal stem cells arise from tissue-specific normal stroma. Stem Cells (Dayton, Ohio). PMID 30353617 DOI: 10.1002/Stem.2932  0.406
2018 McLean K, Tan L, Bolland DE, Coffman LG, Peterson LF, Talpaz M, Neamati N, Buckanovich RJ. Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth. Oncogene. PMID 30305729 DOI: 10.1038/S41388-018-0523-6  0.384
2018 Iyengar M, O'Hayer P, Cole A, Sebastian T, Yang K, Coffman L, Buckanovich RJ. CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer. Oncotarget. 9: 15658-15672. PMID 29644000 DOI: 10.18632/Oncotarget.24585  0.397
2017 Coffman LG, Burgos-Ojeda D, Wu R, Cho K, Bai S, Buckanovich RJ. Abstract TMEM-019: NEW OVARIAN CANCER METASTASIS MODELS DEMONSTRATE PREFERENTIAL HEMATOGENOUS SPREAD OF OVARIAN CANCER CELLS TO THE OVARY AND A REQUIREMENT FOR THE OVARY FOR ABDOMINAL DISSEMINATION Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Tmem-019  0.438
2016 Coffman LG, Burgos-Ojeda D, Wu R, Cho K, Bai S, Buckanovich RJ. New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 27083386 DOI: 10.1016/J.Trsl.2016.03.016  0.422
2016 Coffman LG, Choi YJ, McLean K, Allen BL, di Magliano MP, Buckanovich RJ. Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop. Oncotarget. PMID 26755648 DOI: 10.18632/Oncotarget.6870  0.445
2016 Coffman LG, Choi Y, Mclean K, Magliano MPd, Allen B, Buckanovich RJ. Abstract B60: Identification of an ovarian tumor:stromal HH:BMP4 signaling loop critical to ovarian cancer growth and chemotherapy resistance. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B60  0.444
2016 Iyengar M, Coffman L, Buckanovich R. Abstract A73: CDK4/6 inhibition as maintenance therapy in ovarian cancer. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A73  0.411
2015 Choi YJ, Ingram PN, Yang K, Coffman L, Iyengar M, Bai S, Thomas DG, Yoon E, Buckanovich RJ. Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2. Proceedings of the National Academy of Sciences of the United States of America. PMID 26621735 DOI: 10.1073/Pnas.1507899112  0.401
2013 Coffman L, Mooney C, Lim J, Bai S, Silva I, Gong Y, Yang K, Buckanovich RJ. Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells. Cancer Biology & Therapy. 14: 184-92. PMID 23192269 DOI: 10.4161/Cbt.22959  0.39
2013 Coffman L, Choi Y, Buckanovich R. Abstract B72: Identification of hedgehog signaling between ovarian tumors and carcinoma associated mesenchymal stem cells Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B72  0.421
2011 Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D'Agostino R, Torti SV, Torti FM. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Research. 71: 6728-37. PMID 21875943 DOI: 10.1158/0008-5472.Can-11-1870  0.6
2011 Miller LD, Coffman LG, Chou JW, Black MA, Bergh J, D'Agostino R, Torti SV, Torti FM. Abstract C64: Iron regulatory gene signature predicts outcome in breast cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-C64  0.643
2010 Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: Past, present and future. Biochimica Et Biophysica Acta. 1800: 760-9. PMID 20304033 DOI: 10.1016/J.Bbagen.2010.03.011  0.575
2009 Coffman LG, Parsonage D, D'Agostino R, Torti FM, Torti SV. Regulatory effects of ferritin on angiogenesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 570-5. PMID 19126685 DOI: 10.1073/Pnas.0812010106  0.611
2009 Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Reviews. 23: 95-104. PMID 18835072 DOI: 10.1016/J.Blre.2008.08.001  0.6
2008 Coffman LG, Brown JC, Johnson DA, Parthasarathy N, D'Agostino RB, Lively MO, Hua X, Tilley SL, Muller-Esterl W, Willingham MC, Torti FM, Torti SV. Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin. American Journal of Physiology. Lung Cellular and Molecular Physiology. 294: L505-15. PMID 18192590 DOI: 10.1152/Ajplung.00347.2007  0.549
Show low-probability matches.